Physician profile
Stuart E Fromm
NPI 1881674547
$13,319,978.90
in general payments reported to CMS, 2019-2025
5 companies · $2.0M in 2025
The $2.0M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.6M · 2020: $1.5M · 2021: $1.8M · 2022: $1.9M · 2023: $2.3M · 2024: $2.2M · 2025: $2.0M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $6.5M.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $6,503,670.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $13,030,148.17 | 2019-2025 | Omnispan Orthocord, Rapidloc Pds Panacryl |
| Stryker Corporation | $187,102.51 | 2019-2025 | Knotilus Anchor, 3.5mm |
| Smith+Nephew, INC. | $101,830.65 | 2019-2021 | |
| Depuy Synthes Sales INC. | $793.52 | 2019 | |
| Medical Device Business Services, INC. | $104.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Fromm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.